Therapy for mixed dyslipidaemia through ANGPTL3 inhibition. [Editorial] (2025)
- Autor:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/S0140-6736(25)00613-0
- Subjects: DISLIPIDEMIAS; DOENÇAS CARDIOVASCULARES; PROTEÍNAS
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SANTOS FILHO, Raul Dias dos. Therapy for mixed dyslipidaemia through ANGPTL3 inhibition. [Editorial]. Lancet. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://observatorio.fm.usp.br/handle/OPI/87152. Acesso em: 26 jan. 2026. , 2025 -
APA
Santos Filho, R. D. dos. (2025). Therapy for mixed dyslipidaemia through ANGPTL3 inhibition. [Editorial]. Lancet. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0140-6736(25)00613-0 -
NLM
Santos Filho RD dos. Therapy for mixed dyslipidaemia through ANGPTL3 inhibition. [Editorial] [Internet]. Lancet. 2025 ; 405( 10489): 1558-1559.[citado 2026 jan. 26 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87152 -
Vancouver
Santos Filho RD dos. Therapy for mixed dyslipidaemia through ANGPTL3 inhibition. [Editorial] [Internet]. Lancet. 2025 ; 405( 10489): 1558-1559.[citado 2026 jan. 26 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87152 - Does nonalcoholic fatty liver disease cause cardiovascular disease? Current knowledge and gaps
- Characterizing familial chylomicronemia syndrome: baseline data of the APPROACH study
- Real-world outcomes with lomitapide use in paediatric patients with homozygous familial hypercholesterolaemia
- Sex disparity in the management and outcomes of dyslipidemia of diabetic patients in the Arabian Gulf: findings from the CEPHEUS study
- Vertebral bone density by quantitative computed tomography mirrors bone structure histomorphometric parameters in hemodialysis patients
- Effects of medication, treatment, and behavioral beliefs on intentions to take medication in patients with familial hypercholesterolemia
- Increased subclinical atherosclerosis burden in familial hypercholesterolemia phenotype [Editorial]: What do genetic defects tell us and what are the clinical implications?
- Sodium intake and prevalence of hypertension in elementary school students
- Clinical Genetic Testing for Familial Hypercholesterolemia
- Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab
Informações sobre o DOI: 10.1016/S0140-6736(25)00613-0 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
